News

New study may transform diagnosis of Britain’s number one cancer

Making cancer vaccines more personal

The role of WNT signaling in cancer: from mechanisms to therapeutics

Vitamin-engineered nanoplatforms: Revolutionising precision oncology through immunotherapy, drug delivery, and theranostics

FDA approves revumenib for relapsed or refractory acute myeloid leukaemia with a susceptible NPM1 mutation

FDA approves belantamab mafodotin-blmf for relapsed or refractory multiple myeloma

Common jobs held by immigrant women may put them at increased risk of breast cancer

High levels of specific protein may impair high-risk paediatric neuroblastoma

Hidden immune defense mechanism could be used to fight cancer, says study

New way to destroy a cancer-linked molecule revealed

ESMO 2025: Colon cancer DNA detectable in blood can guide chemo decisions: study

Drug that stops tumour blood supply could have role in paediatric bone cancer